Stock Headlines
COVID-19 Testing Frequency Is Unlikely To Decline And Abbott Labs (ABT) Is Main Beneficiary
The stock of Abbott Labs (ABT) has gained almost 40% over the past year. Sales of COVID-19 tests for the ABT stock were strong, but
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.